Literature DB >> 12642690

The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy.

Anil K Sood1, Mavis S Fletcher, Chris M Zahn, Lynn M Gruman, Jeremy E Coffin, Elisbeth A Seftor, Mary J C Hendrix.   

Abstract

Vasculogenic mimicry reflects the plasticity of aggressive tumor cells that express vascular cell markers and line tumor vasculature; such has been demonstrated in aggressive ovarian carcinoma. This study measured the clinical significance of tumor cell-lined vasculature in ovarian carcinomas (n=77), which was detected in 23 (29.8%) tumors. The data show that tumor cell-lined vasculature was associated with aggressive tumor features and with shorter overall survival (p<0.001). Cox proportional hazards model revealed that tumor cell-lined vasculature (p=0.002) was independently associated with poor survival. This is the first study demonstrating the clinical implications of tumor cell-lined vasculature in ovarian carcinoma.

Entities:  

Mesh:

Year:  2002        PMID: 12642690     DOI: 10.4161/cbt.316

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  37 in total

Review 1.  Mig-7 linked to vasculogenic mimicry.

Authors:  Gavin P Robertson
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

2.  A Matrigel-based tube formation assay to assess the vasculogenic activity of tumor cells.

Authors:  Ralph A Francescone; Michael Faibish; Rong Shao
Journal:  J Vis Exp       Date:  2011-09-07       Impact factor: 1.355

3.  Transforming growth factor-β is required for vasculogenic mimicry formation in glioma cell line U251MG.

Authors:  Gengqiang Ling; Shiyong Wang; Zhenhua Song; Xinlin Sun; Yijing Liu; Xiaodan Jiang; Yingqian Cai; Mouxuan Du; Yiquan Ke
Journal:  Cancer Biol Ther       Date:  2011-12-01       Impact factor: 4.742

4.  Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma.

Authors:  Shi-Yong Wang; Yi-Quan Ke; Guo-Hui Lu; Zhen-Hua Song; Li Yu; Sha Xiao; Xin-Lin Sun; Xiao-Dan Jiang; Zhi-Lin Yang; Chang-Chen Hu
Journal:  J Neurooncol       Date:  2013-02-16       Impact factor: 4.130

5.  Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.

Authors:  Yue-Zu Fan; Wei Sun
Journal:  World J Gastrointest Surg       Date:  2010-04-27

Review 6.  Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives.

Authors:  Bingxue Shang; Zhifei Cao; Quansheng Zhou
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

Review 7.  The merits of vascular targeting for gynecologic malignancies.

Authors:  Aparna A Kamat; Anil K Sood
Journal:  Curr Oncol Rep       Date:  2005-11       Impact factor: 5.075

8.  Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.

Authors:  Alexandra A Mourad-Zeidan; Vladislava O Melnikova; Hua Wang; Avraham Raz; Menashe Bar-Eli
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

9.  Vascular Mimicry: Concepts and Implications for Anti-Angiogenic Therapy.

Authors:  James M Dunleavey; Andrew C Dudley
Journal:  Curr Angiogenes       Date:  2012-06-01

10.  Microgenomics profile the endogenous angiogenic phenotype in subpopulations of aggressive melanoma.

Authors:  Zoe N Demou; Mary J C Hendrix
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.